Incidence and risk factors of immune checkpoint inhibitor-induced colitis in Korean patients with cancer
Background/Aims Immune checkpoint inhibitors (ICIs) are effective in treating cancer. However, various immune-related adverse events (irAEs) have become prevalent, with ICI-induced colitis being the most common gastrointestinal irAE. Thus, we aimed to investigate the incidence and risk factors of IC...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Korean Association of Internal Medicine
2025-01-01
|
| Sarja: | The Korean Journal of Internal Medicine |
| Aiheet: | |
| Linkit: | http://kjim.org/upload/kjim-2024-135.pdf |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|